122 related articles for article (PubMed ID: 5701828)
1. [Comparison among single, double and triple drug regimens in retreatment. (the seventh series of the trial, B)].
Kekkaku; 1968 Jun; 43(6):199-207. PubMed ID: 5701828
[No Abstract] [Full Text] [Related]
2. [Treatment of drug resistant chronic pulmonary tuberculosis with a number of tuberculostatics].
Bernard E
Bull Int Union Tuberc; 1968 Dec; 41():183-7. PubMed ID: 4303862
[No Abstract] [Full Text] [Related]
3. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
Fegiz G
Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
[No Abstract] [Full Text] [Related]
4. Ethambytol in the retreatment of pulmonary tuberculosis. United States Public Health Service cooperative trial.
Steininger WJ
Bull Int Union Tuberc; 1968 Dec; 41():181-2. PubMed ID: 4303861
[No Abstract] [Full Text] [Related]
5. Evaluation of kanamycin in a triple regimen of kanamycin, cycloserine and ethionamide in the treatment of far-advanced cases of pulmonary tuberculosis with tubercle bacilli resistant to primary drugs.
Oka S; Motomiya M; Kato S; Sato H; Fujimoto M
Sci Rep Res Inst Tohoku Univ Med; 1967 Apr; 14(1):91-3. PubMed ID: 4968094
[No Abstract] [Full Text] [Related]
6. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
Bignall JR
Bull Int Union Tuberc; 1968 Dec; 41():175-7. PubMed ID: 4885379
[No Abstract] [Full Text] [Related]
7. Comparison of the combination therapy of capreomycin. Ethionamide. Cycloserine with that of kanamycin. Ethionamide. Cycloserin in the retreatment of pulmonary tuberculosis.
Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):1-13. PubMed ID: 4990959
[No Abstract] [Full Text] [Related]
8. Comparative studies of various antituberculosis drug regimens by means of serum antimycobacterial activity tests in man.
Hokama S
Jpn J Tuberc; 1967 Jul; 14(1):55-65. PubMed ID: 5300098
[No Abstract] [Full Text] [Related]
9. [Comparison of combination therapy of Capreomycin, ethionamide and cycloserin with that of kanamycin, ethionamide and cycloserin for the retreatment of pulmonary tuberculosis].
Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
Saishin Igaku; 1970 Jul; 25(7):1546-55. PubMed ID: 5451178
[No Abstract] [Full Text] [Related]
10. [Effect and toxicity on the combined use of pyrazinamide, ethionamide and kanamycin in the retreatment of pulmonary tuberculosis (author's transl)].
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1979; 2(4):199-200. PubMed ID: 555425
[No Abstract] [Full Text] [Related]
11. [Comparative study of two regimens, KM-TH-CS and KM-TH-EB, in retreatment cases of pulmonary tuberculosis].
Aoyagi T; Fukuhara Y; Hondo G; Matsumiya T; Murata A
Kekkaku; 1970 Jan; 45(1):27-36. PubMed ID: 5416951
[No Abstract] [Full Text] [Related]
12. [Bacterial resistance tests against secondary antitubercular agents--reliability of the routine methods].
Tsukamura M
Iryo; 1966 Mar; 20(3):241-50. PubMed ID: 5964831
[No Abstract] [Full Text] [Related]
13. Cycloserine plus ethionamide plus pyrazinamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli following previous chemotherapy.
Ramakrishnan CV; Parthasarathy R; Sambamoorthy S; Somasundaram PR; Subbammal S
Indian J Med Res; 1976 Jan; 64(1):76-82. PubMed ID: 818010
[No Abstract] [Full Text] [Related]
14. [Administration of reserve antitubercular drugs in a single daily dose].
Bek E; Bukalska Z; Zachara A
Gruzlica; 1968; 37(1):43-7. PubMed ID: 5720037
[No Abstract] [Full Text] [Related]
15. [Th 13-14 and PZA and CS in the treatment of chronic cavitary tuberculosis with bacterial resistance to classic antibacterial drugs].
Zunić D
Tuberkuloza; 1966; 18(5):429-40. PubMed ID: 16296047
[No Abstract] [Full Text] [Related]
16. Treatment of patients with drug-resistance in economically developed countries.
Crofton J
Tubercle; 1969 Mar; 50():Suppl:65-8. PubMed ID: 4319134
[No Abstract] [Full Text] [Related]
17. [Pyrazinamide, cycloserine and ethionamide in the complex treatment of pulmonary tuberculosis].
Aspevik E
Tidsskr Nor Laegeforen; 1967 Mar; 87(6):548-54. PubMed ID: 6047184
[No Abstract] [Full Text] [Related]
18. CHEMOTHERAPY REGIMENS USED IN RETREATMENT OF PULMONARY TUBERCULOSIS. I. OBSERVATIONS ON THE EFFICACY OF COMBINATIONS OF KANAMYCIN, ETHIONAMIDE AND EITHER CYCLOSERINE OR PYRAZINAMIDE.
KASS I
Tubercle; 1965 Jun; 46():151-65. PubMed ID: 14327963
[No Abstract] [Full Text] [Related]
19. Ethambutol in the treatment of 26 patients with chronic active pulmonary tuberculosis.
Jesiotr M
Tubercle; 1969 Mar; 50():Suppl:54-5. PubMed ID: 4319133
[No Abstract] [Full Text] [Related]
20. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
Bignall JR; Lind A; Rist N
Bull Int Union Tuberc; 1969 Aug; 42():7-57. PubMed ID: 5004884
[No Abstract] [Full Text] [Related]
[Next] [New Search]
